Conservative Kidney Management: When, Why, and For Whom?

被引:1
|
作者
Li, Kelly Chenlei [1 ,2 ]
Brown, Mark Ashley [1 ]
机构
[1] Univ New South Wales, St George Hosp, Renal Dept, Sydney, Australia
[2] 50 Montgomery St,Suite 1, Kogarah, NSW 2217, Australia
关键词
Shared decision making; kidney failure; end stage kidney disease; conservative kidney management; kidney supportive care; palliative care; STAGE RENAL-DISEASE; OF-LIFE; PALLIATIVE CARE; COMPARATIVE SURVIVAL; STARTING DIALYSIS; ELDERLY-PATIENTS; DECISION-MAKING; OLDER PATIENTS; CKD; PATIENT;
D O I
10.1016/j.semnephrol.2023.151395
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Deciding between dialysis and conservative kidney management (CKM) in an elderly or seriously ill per-son with kidney failure is complex and requires shared decision making. Patients and families look to their nephrolo-gist to provide an individualized recommendation that aligns with patient-centered goals. For a balanced and considered decision to be made, dialysis should not be the default and nephrologists need to be familiar with rele-vant prognostic information including survival, symptom burden, functional trajectory, and quality of life with dialysis and with CKM. CKM is a holistic, proactive, and multidisciplinary treatment for kidney failure. For some elderly comorbid patients, CKM improves symptom burden and aligns with quality-of-life goals, with modest or no loss of longevity. CKM can be provided by a nephrologist alone but ideally is managed through partnership with a dedi-cated supportive or palliative care service embedded within the nephrology practice. Treatment decisions are best discussed early in the disease trajectory and occur over many consultations, and nephrologists should be upskilled in communication to better support patients and families in these important conversations. Nephrologists should remain actively involved in their patients' care through to end-of-life care. Semin Nephrol 43:151395 & COPY; 2023 Elsevier Inc. All rights reserved.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Modern management of diabetic foot osteomyelitis. The when, how and why of conservative approaches
    Aragon-Sanchez, Javier
    Lipsky, Benjamin A.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (01) : 35 - 50
  • [22] Operating room management:: why, how and by whom?
    Marjamaa, R.
    Vakkuri, A.
    Kirvela, O.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2008, 52 (05) : 596 - 600
  • [23] Introduction: Conservative Kidney Management
    Gelfand, Samantha
    SEMINARS IN NEPHROLOGY, 2023, 43 (01)
  • [25] Challenging the Universality of Job Resources: Why, When, and For Whom Are They Beneficial?
    Van Veldhoven, Marc
    Van den Broeck, Anja
    Daniels, Kevin
    Bakker, Arnold B.
    Tavares, Susana M.
    Ogbonnaya, Chidiebere
    APPLIED PSYCHOLOGY-AN INTERNATIONAL REVIEW-PSYCHOLOGIE APPLIQUEE-REVUE INTERNATIONALE, 2020, 69 (01): : 5 - 29
  • [26] Enteral Nutrition: Whom, Why, When, What and Where to Feed?
    Reddy, B. Ravinder
    IMPORTANCE OF NUTRITION AS AN INTEGRAL PART OF DISEASE MANAGEMENT, 2015, 82 : 53 - 59
  • [27] Screening for osteoporosis after breast cancer: For whom, why and when
    Tremollieres, Florence A.
    MATURITAS, 2014, 79 (03) : 343 - 348
  • [28] Prone position in ARDS patients: why, when, how and for whom
    Guerin, Claude
    Albert, Richard K.
    Beitler, Jeremy
    Gattinoni, Luciano
    Jaber, Samir
    Marini, John J.
    Munshi, Laveena
    Papazian, Laurent
    Pesenti, Antonio
    Vieillard-Baron, Antoine
    Mancebo, Jordi
    INTENSIVE CARE MEDICINE, 2020, 46 (12) : 2385 - 2396
  • [29] When, how, why and whom for there will be an "after" Covid-19?
    Tognoni, Gianni
    ASSISTENZA INFERMIERISTICA E RICERCA, 2020, 39 (03) : 147 - 153
  • [30] Sex Education In India: Why, What, When, Where, Whom?
    Kar, Sujita Kumar
    Singh, Abhisek Pratap
    Prakash, Om
    Tripathi, Adarsh
    INDIAN JOURNAL OF PSYCHIATRY, 2017, 59 (06) : S159 - S159